Night shift Workers' gut bugs under the microscope
NCT ID NCT03221517
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how working night shifts changes the bacteria in your gut and how your body handles sugar. Researchers will compare 12 healthy men who work night shifts with those who work during the day. They will track gut bacteria and blood sugar levels at different times of day to understand why shift workers have higher disease risk.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Standardized meal with glucose challenge test
- What this could lead to
- If successful, this could reveal how shift work disrupts gut bacteria, pointing toward ways to reduce disease risk in shift workers.
- What could go wrong
- This is a very small, early observational study with only 12 participants, so findings may not apply broadly. It does not test any treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 12 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2017
- Expected to finish
-
Nov 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 to 59 years
- Sex
-
Male participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Cohort 1: healthy un-medicated males (to limit gender-induced variability similar to our pilot study), shift-work schedule (\>3 shifts per month outside 7am-6pm (9)) for the past ≥10 years, 40-59 years old (increased prevalence of the metabolic syndrome at ≥60 years of age (20)); * Cohort 2: day workers who work 7am-6pm for ≥10 years matched for line of work, age, gender, and BMI; * Volunteers are capable of giving informed consent; * 40-59 years of age; * Own an android smartphone which installs the remote sensing applications (those with apple smartphones will not be recruited); * Non-smoking; * Male subjects * The use of contraception will NOT be required for male participants. Exclusion Criteria: * Recent travel across more than two (2) time zones (within the past month); * Planned travel across more than two (2) time zones during the planned study activities; * Use of illicit drugs; * High dose vitamins (Vitamin A, Vitamin C, Vitamin E, Beta Carotene, Folic Acid and Selenium), alcohol and any over-the counter NSAID in the (2) two weeks before the start of the 48 hour deep phenotyping; * High fat foods and caffeine in the past 24 hours prior to the 48-hour deep chronotyping session; * History of abdominal surgery; * Known allergy or intolerance to Vancomycin, and/or Neomycin; * Use of anticholinergics in the week prior to the 48-hour sessions; * Use of laxatives or anti-diarrhea medications in the two weeks prior to the 48-hour sessions; * Subjects, who have received an experimental drug, used an experimental medical device within 30 days prior to screening, or who gave a blood donation of ≥ one pint within 8 weeks prior to screening; * Subjects with any abnormal laboratory value or physical finding that according to the investigator may interfere with interpretation of the study results, be indicative of an underlying disease state, or compromise the safety of a potential subject;
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania, 19104, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a protein powder with creatine and fiber boost everyday Well-Being?
- Green tech or hidden stress? bus Drivers' hearts monitored behind the wheel
- Shout it out: can growls and screams raise pain tolerance?
- Scientists probe why brain stimulation works for some and not others
- Tiny doses, big questions: how does the body handle this prodrug?
- First human test of CM583: can this biologic pass the safety check?